Menu

• Ask a Health Expert about CEREBRAL HYGROMA
• Post Your Side Effect related to CEREBRAL HYGROMA
• CEREBRAL HYGROMA and FDA Warnings
• CEREBRAL HYGROMA in Patients Wiki
• Report CEREBRAL HYGROMA in Drug Side Effect Survey

CEREBRAL HYGROMA side effect

What is CEREBRAL HYGROMA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Aripiprazole Side Effects Report #5747719-8
Consumer or non-health professional from CZECH REPUBLIC reported ARIPIPRAZOLE problem on May 19, 2008. Male patient, 48 years of age, was treated with ARIPIPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cerebral hygroma, convulsion, diabetic hyperosmolar coma, epistaxis, fall, laceration, muscle contractions involuntary, tremor, . ARIPIPRAZOLE dosage: unknown. During the same period patient was treated with COGENTIN, DEPAKOTE ER, KLONOPIN, DIPHENHYDRAMINE. Patient was hospitalized. Patient recovered.

Aripiprazole Side Effects Report #5750725-0
ARIPIPRAZOLE problem was reported by a Consumer or non-health professional from CZECH REPUBLIC on May 19, 2008. Male patient, 48 years of age, was treated with ARIPIPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cerebral hygroma, convulsion, diabetic hyperosmolar coma, epistaxis, fall, laceration, muscle contractions involuntary, tremor, . ARIPIPRAZOLE dosage: unknown. During the same period patient was treated with COGENTIN, DEPAKOTE ER, KLONOPIN, DIPHENHYDRAMINE. Patient was hospitalized. Patient recovered.

Gliadel Side Effects Report #5484455-X
Physician from UNITED STATES reported GLIADEL problem on Oct 03, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: arachnoiditis, cerebral hygroma, hydrocephalus, hyponatraemia, intracranial hypotension, meningitis, postoperative wound infection, pyrexia, . GLIADEL dosage: unknown. Patient recovered.

Gliadel Side Effects Report #5490043-1
GLIADEL problem was reported by a Physician from UNITED STATES on June 27, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: arachnoiditis, cerebral hygroma, hydrocephalus, hyponatraemia, intracranial hypotension, meningitis, postoperative wound infection, . GLIADEL dosage: unknown. Patient recovered.


Daclizumab Side Effects Report #5391419-3
Physician from NETHERLANDS reported DACLIZUMAB problem on July 11, 2007. Male patient, 67 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, cerebral hygroma, . DACLIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5391419-3
DACLIZUMAB problem was reported by a Physician from NETHERLANDS on July 11, 2007. Male patient, 67 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, cerebral hygroma, . DACLIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.

Lovaza Side Effects Report #5526188-7
Consumer or non-health professional from SWEDEN reported LOVAZA problem on Nov 09, 2007. Male patient, 78 years of age, was diagnosed with diabetes mellitus and was treated with LOVAZA. After drug was administered, patient experienced the following problems/side effects: brain oedema, cerebral haemorrhage traumatic, cerebral hygroma, dizziness, fall, speech disorder, subarachnoid haemorrhage, subdural haematoma, . LOVAZA dosage: unknown. During the same period patient was treated with LANTUS, OPTIPEN INSULIN APPLICATOR, OMEPRAZOLE, NITRATES, METOPROLOL, SIMVASTATIN, ALLOPURINOL, RAMIPRIL. Patient was hospitalized. Patient recovered.

Telzir Side Effects Report #5501997-9
TELZIR problem was reported by a Physician from FRANCE on Oct 24, 2007. Male patient, 42 years of age, weighting 143.3 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, bulimia nervosa, cerebral hygroma, confusional state, csf glucose decreased, csf protein decreased, delirium, dyskinesia, encephalitis, . TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with TRUVADA, VIREAD, EMTRIVA, NORVIR. Patient was hospitalized and became disabled. Patient recovered.

Telzir Side Effects Report #5707037-0
Physician from FRANCE reported TELZIR problem on Apr 08, 2008. Male patient, 42 years of age, weighting 143.3 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, bulimia nervosa, cerebral hygroma, confusional state, csf glucose decreased, csf protein decreased, delirium, dyskinesia, encephalitis, . TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with TRUVADA, VIREAD, EMTRIVA, NORVIR. Patient was hospitalized and became disabled. Patient recovered.